AI steps in to make safer breast scans just as accurate
NCT ID NCT04340180
Summary
This study tested whether artificial intelligence (AI) could help radiologists accurately identify breast tumors on MRI scans that use a much lower dose of contrast dye. Twenty women, half with benign conditions and half with cancer, received both a standard and a low-dose scan. Researchers compared how well doctors could spot and describe tumors using the low-dose images alone versus the low-dose images processed by AI.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST BENIGN TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Kirklin Clinic
Birmingham, Alabama, 35249, United States
Conditions
Explore the condition pages connected to this study.